A recent study found that the ferroptosis inducer erastin can induce cellular autophagy, and autophagy can trigger ferroptosis by degrading ferritin and transferrin receptor 1 (TfR1), resulting in the accumulation of intracellular iron
It can help patients lose considerable amounts of weight, similar to what was previously only medically achievable with more invasive surgical interventions
It has been later used for the treatment of Crohns disease, ulcerative colitis, chronic diarrhea and diverticulitis [50]
Fibre content is a crucial consideration when selecting carbohydrates
Eli Lilly is currently in Phase 3 clinical trials with orforglipron
Conditions such as hypothyroidism, Cushing's syndrome, polycystic ovary syndrome, or medication-induced weight gain should be considered